Delivery Order SPE2DB20D2104-SPE2DB26FMBLG
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a ceiling value of $81,786.40. This competitively awarded, firm fixed-price delivery order is set to be completed by September 9, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,130.81 on July 31, 2025, for the supply of Jardiance 25 mg tablets (90-count units). This firm fixed-price, competitively awarded contract has an ultimate completion date of August 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Jardiance 25 mg tablets (90-count packaging) valued at $6,733.04 under a firm fixed-price contract. This non-set-aside delivery order is scheduled for completion by October 24, 2025, and will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a single delivery order against AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Jardiance 25 mg tablets (90-count packages) valued at $6,762.21 under a firm fixed-price contract structure. The award was made without a set-aside designation, indicating open competition. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Jardiance 10 mg tablets (90-count) under a firm fixed-price contract valued at $21,295.85. This non-competitive, competitively awarded delivery order is scheduled for completion by August 21, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a contract ceiling value of $34,614.62. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The order is scheduled for completion by May 7, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $17,796.50 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Jardiance 10 mg tablets (90-count units) with a ceiling value of $9,798.71. This competitive, non-set-aside award is structured as a firm fixed price delivery order with an ultimate completion date of August 11, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Jardiance 25 mg tablets (90-count packages) with a contract value of $5,425.98 and a completion date of September 3, 2025. This delivery order represents a firm fixed-price, non-set-aside award made through open competition, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement requirements. The place of performance is located...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $32,975.40 on October 29, 2025, for the supply of Jardiance 25 mg tablets in quantities of 90 units. This firm fixed-price, non-set-aside contract is scheduled for completion by October 30, 2025, with performance taking place at the company's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's ongoing role as a critical pharmaceutical supplier to...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB26FMBLGDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a ceiling value of $7,736.36. This is a firm fixed price delivery order with an ultimate completion date of October 31, 2025, and represents a non-competitive set-aside contract. The order will be fulfilled at AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal healthcare vendor, particularly for Defense Health Agency, U.S. Coast Guard, and other government medical systems. The company's contract portfolio with the Defense Logistics Agency demonstrates extensive capability in fulfilling federal pharmaceutical procurement requirements across multiple therapeutic domains, including diabetes medications, neurological treatments, pain management pharmaceuticals, and specialized medical supplies. The award of this Jardiance delivery order reflects AmerisourceBergen's established position as a primary supplier within the DLA's pharmaceutical supply chain and its ability to meet federal medical procurement standards through competitive contracting mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.7k | 10/30/25 |